Epiva Biosciences' Merger

Epiva Biosciences raised a round of funding on July 12, 2016. Investors include Evelo Biosciences.

Epiva Therapeutics is a microbiome company focused on microbiome-based therapeutics for the treatment of autoimmune diseases that possess a microbiome signature characterized by dysbiosis.…

Articles about Epiva Biosciences' Merger: